NEO6860

DRUG2 trials

Sponsors

Neomed Institute

Conditions

Osteoarthritis of the KneeOsteoarthritis, KneePain

Phase 1

NEO6860, a TRPV1 Antagonist, First in Human Study

CompletedNCT02337543

Neomed InstituteOsteoarthritis, Knee

Start: 2015-01-31End: 2015-07-31Updated: 2016-03-10

Phase 2

A Proof-of-Concept Study Assessing NEO6860 in Osteoarthritis Pain

CompletedNCT02712957

Neomed InstituteOsteoarthritis of the Knee, Pain

Start: 2016-03-31End: 2016-11-24Updated: 2017-03-13